Moasser, Mark M <br/><br/>
The Evolving Landscape of HER2 Targeting in Breast Cancer.  [electronic resource] 

 -  JAMA oncology  Nov 2015 
 - 1154-61 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review 
<br/><br/><label>ISSN: </label>2374-2445 
<br/><br/><label>Standard No.: </label>10.1001/jamaoncol.2015.2286  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--adverse effects<br/>Biomarkers, Tumor--antagonists & inhibitors<br/>Breast Neoplasms--drug therapy<br/>Female<br/>Genetic Predisposition to Disease<br/>Genetic Testing<br/>Humans<br/>Molecular Targeted Therapy--adverse effects<br/>Phenotype<br/>Precision Medicine<br/>Protein Kinase Inhibitors--adverse effects<br/>Receptor, ErbB-2--antagonists & inhibitors<br/>Signal Transduction--drug effects<br/>Treatment Outcome